TD Cowen raised the firm’s price target on Versigent (VGNT) to $49 from $47 and keeps a Buy rating on the shares. The firm said a positive/reassuring outcome on a solid Q1, fully confirmed 2026 guidance and positive capital allocation announcements including an intention to initiate a dividend and $250mln share repurchase program.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VGNT: